Seizert Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-460,261
| Closed | -$16.7M | – | 241 |
|
|
2016
Q4 | $16.7M | Buy |
460,261
+68,561
| +18% | +$2.49M | 0.59% | 53 |
|
|
2016
Q3 | $18M | Buy |
391,700
+181,606
| +86% | +$8.36M | 0.67% | 52 |
|
|
2016
Q2 | $10.6M | Buy |
210,094
+60,224
| +40% | +$3.03M | 0.4% | 65 |
|
|
2016
Q1 | $8.02M | Buy |
149,870
+42,384
| +39% | +$2.27M | 0.27% | 75 |
|
|
2015
Q4 | $7.06M | Sell |
107,486
-8,051
| -7% | -$528K | 0.22% | 81 |
|
|
2015
Q3 | $6.52M | Sell |
115,537
-51,391
| -31% | -$2.9M | 0.2% | 85 |
|
|
2015
Q2 | $9.87M | Buy |
166,928
+5,141
| +3% | +$304K | 0.25% | 79 |
|
|
2015
Q1 | $10.1M | Sell |
161,787
-2,781
| -2% | -$173K | 0.25% | 81 |
|
|
2014
Q4 | $9.46M | Buy |
164,568
+182
| +0.1% | +$10.5K | 0.2% | 81 |
|
|
2014
Q3 | $8.84M | Sell |
164,386
-5,149
| -3% | -$277K | 0.18% | 83 |
|
|
2014
Q2 | $8.89M | Buy |
169,535
+72,807
| +75% | +$3.82M | 0.18% | 81 |
|
|
2014
Q1 | $5.11M | Buy |
+96,728
| New | +$5.11M | 0.12% | 79 |
|
|
2013
Q3 | – | Sell |
-7,960
| Closed | -$312K | – | 214 |
|
|
2013
Q2 | $312K | Buy |
+7,960
| New | +$312K | 0.01% | 167 |
|